Following stimulation with antigen or polyclonal mitogen, resting human B lymphocytes become activated, proliferate, and subsequently differentiate into antibody secreting cells. This sequence can be delineated by a series of morphologic, metabolic, molecular, and cell surface antigenic events. The focus of this proposal is to study the function of those cell surface structures which are not expressed on resting B cell but appear with activation. These activation antigen (ActAgs) are excellent candidates for those structures which may have a regulatory role in the control of B cell proliferation and differentiation or are involved in cell-cell interactions, in localization, or in adhesion of activated B cells within a microenvironment.
The aims of the present project are to examine the function of selected B cell activation antigens by: 1) examining the response of activated B cell populations to growth and differentiation factors; 2) developing monoclonal antibodies (MAbs) directed against previously described ActAgs in an attempt to identify functionally important epitopes; 3) using MAbs directed against ActAgs to induce or inhibit proliferation and/or differentiation in vitro; and 4) using MAbs directed against ActAgs to determine whether the molecule is involved in cell-cell interactions. To achieve the first aim, I will identify and isolate populations of B cells which express an ActAg and examine their responses in B cell functional assays. For the second aim, I will utilize novel immunization techniques employing B cell ActAg cDNA transfected into cos cells. In the third and fourth specific aims, I will attempt to examine the function of the Ag using MAbs to mimic natural ligands or inhibit cell-cell interactions. These studies should provide a biologic basis with which to eventually examine human B cell malignancies as subpopulations of activated B cells and to attempt to correlate their clinical presentation and disease course with the subpopulation of B cells from which they are derived.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08CA001105-05
Application #
3079609
Study Section
Cancer Institutional Fellowship Review Committee (CT)
Project Start
1986-08-01
Project End
1991-06-30
Budget Start
1990-08-01
Budget End
1991-06-30
Support Year
5
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02215
Soiffer, R J; Murray, C; Mauch, P et al. (1992) Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow. J Clin Oncol 10:1191-200
Freedman, A S; Ritz, J; Neuberg, D et al. (1991) Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma. Blood 77:2524-9
Freedman, A S; Freeman, G J; Rhynhart, K et al. (1991) Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway. Cell Immunol 137:429-37
Anderson, K C; Barut, B A; Ritz, J et al. (1991) Monoclonal antibody-purged autologous bone marrow transplantation therapy for multiple myeloma. Blood 77:712-20
Savage, C O; Hughes, C C; Pepinsky, R B et al. (1991) Endothelial cell lymphocyte function-associated antigen-3 and an unidentified ligand act in concert to provide costimulation to human peripheral blood CD4+ T cells. Cell Immunol 137:150-63
Freedman, A S; Nadler, L M (1991) Cellular interactions within the germinal centre. Res Immunol 142:232-6
Valle, A; Garrone, P; Yssel, H et al. (1990) mAb 104, a new monoclonal antibody, recognizes the B7 antigen that is expressed on activated B cells and HTLV-1-transformed T cells. Immunology 69:531-5
Berrebi, A; Bassous-Guedj, L; Vorst, E et al. (1990) Further characterization of prolymphocytic leukemia cells as a tumor of activated B cells. Am J Hematol 34:181-5
Tedder, T F; Penta, A C; Levine, H B et al. (1990) Expression of the human leukocyte adhesion molecule, LAM1. Identity with the TQ1 and Leu-8 differentiation antigens. J Immunol 144:532-40
Buchwald, D; Freedman, A S; Ablashi, D V et al. (1990) A chronic ""postinfectious"" fatigue syndrome associated with benign lymphoproliferation, B-cell proliferation, and active replication of human herpesvirus-6. J Clin Immunol 10:335-44

Showing the most recent 10 out of 22 publications